All Articles

A massive conditional loan from the Pentagon's investment arm aims to transform a Utah uranium mill into a cornerstone of America's critical minerals strategy.

A 'dream team' of pharma veterans has raised $180M to advance a next-gen oral drug, promising to transform the multi-billion dollar IBD market.

As air disc brakes become the new standard, DRiV's Abex brand moves beyond parts to offer an integrated system, simplifying maintenance and boosting safety.

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?

Cross Timbers Royalty Trust's June distribution reveals a complex narrative of divergent commodity prices, falling volumes, and persistent operational costs.

As OMS Energy prepares its FY2026 results, its performance offers a unique window into the future of oil & gas in the pivotal Asia-MENA corridor.

Bitdeer reports a 370% surge in Bitcoin mining while aggressively converting its global power grid to support AI, deploying top-tier NVIDIA GPUs.

Latin American software acquirer Nuvini is betting its future on 100% employee AI adoption, using an internal prize to transform its entire workforce.

Ambow Education launches HybriU ProjectHub, an AI platform aiming to unify a chaotic landscape of apps. But can it break through in a market dominated by titans?

Asimov's AI-driven synthetic biology platform partners with McGill's Goodman Cancer Institute, aiming to break the manufacturing bottleneck for complex drugs.

A new patent gives CervoMed a long runway for its dementia drug, but can this IP victory secure the massive funding needed to cross the finish line?

A2MAC1's Tset acquisition is set to redefine automotive cost management, blending deep data with AI simulation to create a dynamic decision-making engine.

As WestJet and the Blue Jays prepare a 'big-league reveal,' we analyze the strategic infrastructure of a partnership shaping fan loyalty and air travel.

Hisense enters Hong Kong with a flagship store, leveraging World Cup fever to showcase its premium RGB MiniLED TVs and signaling a strategic push into the GBA.

Merck secures a pivotal FDA approval for its CAPVAXIVE vaccine, offering new hope for at-risk youth and challenging rivals in the high-stakes pneumococcal market.

As Lindsay Corp prepares its Q3 report, investors are watching how the firm balances weak farm sentiment against rising demand for water-saving tech.

As CFO Dave Denton departs for the consumer goods sector, Pfizer taps a 20-year veteran for the interim role, signaling continuity amid a crucial post-acquisition phase.

An award for a small UK agency reveals a powerful trend: the future isn't about generic platforms, but purpose-built digital ecosystems that create real value.

A Filipino student's award-winning bathroom design highlights a major market shift. LIXIL's American Standard is capitalizing on the multigenerational home trend.

Opendorse is pivoting from an NIL marketplace to a commerce engine, launching Athlete Commerce Media to directly link college athlete influence to sales at major retailers.